"The dermatology team at Tufts MC offers both cosmetic and medical services. The Laser and Cosmetic Clinic offers procedures for Crow’s feet and wrinkles, while specialists at the Psoriasis and Psoriatic Arthritis Center aim to help their patients live comfortably with a skin disease. Other conditions treated include: atopic dermatitis, autoimmune and connective tissue disease, and skin cancer."

During the past decade, Tufts Medical Center, Department of Dermatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tufts Medical Center, Department of Dermatology" #1 collaborator was "Amgen" with 2 trials as a collaborator, "American Contact Dermatitis Society (ACDS)" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "DUSA Pharmaceuticals, Inc." with 1 trials as a collaborator and "Immune Control" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Tufts Medical Center, Department of Dermatology" are "Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials), "Actinic Cheilitis" (1 trials), "Allergic Contact Dermatitis" (1 trials) and "Allergy" (1 trials). Many other conditions were trialed in "Tufts Medical Center, Department of Dermatology" in a lesser frequency.

Most popular intervention types in "Tufts Medical Center, Department of Dermatology" are "Drug" (5 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (2 trials), "Adalimumab (Humira)" (1 trials), "Crisaborole Topical Ointment" (1 trials), "Fluphenazine" (1 trials) and "Methotrexate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tufts Medical Center, Department of Dermatology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Tufts Medical Center, Department of Dermatology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Tufts Medical Center, Department of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tufts Medical Center, Department of Dermatology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".